Accelerating Adoption of Patient-centered Cervical Cancer Screening and Treatment Linkage in Kenya

This study aims to test the use of a multi-component care strategy (DADA LINK) designed to improve cervical cancer screening and linkage to treatment. The duration of the trial is 12 months, with a 6-month follow-up period to evaluate intervention costs and measure maintenance of the care strategies. Study staff at each clinic will abstract data on cervical cancer screening and triage/treatment. Clinics randomized to the intervention arm will have care coordinators who motivate clinic staff to adhere to cervical cancer care guidelines, conduct patient exit surveys to assess intervention fidelity, and support care coordination through use of the mHealth platform (WEMA).

NCT Number	NCT07050745
Lead Sponsor	Kenyatta National Hospital Collaborators: Emory University, University of Washington, National Cancer Institute (NCI), Kenya Ministry of Health, Queen's University, University of Nairobi
Conditions	Cervical Cancer, Cervical Cancer Screening, HPV DNA
Enrollment	1,980 participants
Start Date	2025-12-01
Primary Completion	2026-12 (estimated)
Study Completion	2026-12 (estimated)
Updated on ClinicalTrials.gov	2026-01-12